Euro-Peristat Newsletter: July 2019 Issue n°7
To view in browser click here |
|
|
EURO-PERISTAT NEWSLETTER |
|
Issue n°7 - July 2019 |
|
|
|
ConcePTION: 'Building a pan-European Ecosystem for Generating, Monitoring, and Providing Robust Information on Medication Safety in Pregnancy and Breastfeeding' |
|
|
|
|
The ConcePTION project aims to generate reliable evidence-based information on the safety of medications used during pregnancy and breastfeeding; it brings together 88 organizations from 22 countries, including the European Medicines Agency, drug manufacturers, academia, public health organizations, and teratology networks. These partners will work together to make better use of existing health data from routine, daily practice, to enhance methods of collecting patient-reported data, and to develop new research capabilities.
|
|
|
ConcePTION is supported by the Innovative Medicines Initiative (IMI), a public-private partnership between the European Union and the European pharmaceutical industry. The consortium, comprising close to 200 researchers, is governed and managed by a balanced 50/50 split of public and private partners, and is jointly led by Novartis and the University Medical Center Utrecht.
Euro-Peristat is contributing its expertise to assist with the standardisation of perinatal health outcomes in research on use of medications during pregnancy.
For more information, see the project’s press release here.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
To unsubscribe, click here |
|
|
|